InvestorsHub Logo
Followers 826
Posts 119448
Boards Moderated 15
Alias Born 09/05/2002

Re: Democritus_of_Abdera post# 2402

Thursday, 04/28/2011 5:37:15 PM

Thursday, April 28, 2011 5:37:15 PM

Post# of 2446
Is SRDX still working on a long-acting formulation of Lucentis? If so, readers may be interested in the results of the CATT study reported today:

#msg-62547005 Data
#msg-62550310 Musings on commercial significance for Roche/NVS
#msg-62552160 NEJM editorial
#msg-62552160 Musings on dosing frequency

Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRDX News